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Abstract: This study aimed to address knowledge gaps related to the prevention and management 
of mental health responses among those with a condition that presents risk of severe COVID-19 
infection. A scoping review that mapped English and Chinese-language studies (2019–2020) located 
in MEDLINE (Ovid), Cumulative Index to Nursing and Allied Health Literature (CINAHL), 
PsycInfo, Sociological Abstracts, Embase, China National Knowledge Infrastructure (CNKI), Wan-
fang Data, and Airiti Library was undertaken. Search terms related to COVID-19, mental health, 
and physical health were used and articles that included all three of these factors were extracted (n 
= 77). With the exception of one hospital-based pilot study, there were no intervention studies tar-
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geting mental health in those at risk of severe COVID-19 infection. Promising practices such as in-
tegrated care models that appropriately screen for mental health issues, address health determi-
nants, and include use of digital resources were highlighted. Patient navigator programs, group 
online medical visits, peer support, and social prescribing may also support those with complex 
needs. Future policies need to address digital health access inequities and the implementation of 
multi-integrated health and social care. Furthermore, research is needed to comprehensively assess 
multi-integrated interventions that are resilient to public health crises. 
Keywords: COVID-19; mental health; substance use; chronic diseases 
 
1. Introduction 
The COVID-19 pandemic has presented many mental health challenges, particularly 
for those with physical health conditions who are at risk for severe novel coronavirus 
pneumonia [1]. Circumstances which have contributed to poor mental health include the 
impacts of quarantine (e.g., social isolation), social distancing, altered health care access, 
being in an extended and uncertain emergency state, unexpected unemployment, eco-
nomic despair, complicated grief, and fear of morbidity and mortality from COVID-19 
infection [2–6]. In accordance with the Mental Health Continuum Model, all people, re-
gardless of pre-existing conditions or diagnoses, have the potential to live a flourishing, 
joyful life [7]. Although COVID-19 has challenged people’s health and well-being, there 
is opportunity to better understand how future policies, programs, and initiatives may be 
modified to strengthen the mental health assets of different populations. 
Although there has been much written about generic ways to promote mental health 
during COVID-19, there is limited information about what specific mental health promo-
tion interventions are most effective for those with physical health conditions that put 
them at risk of severe infection from contracting COVID-19. Previous literature about in-
terventions to reduce the psychological impact of pandemics is limited. The Economic and 
Social Research Institute in Dublin produced a working paper [8] which considered pro-
social behaviors, communication, risk perception, and the impacts of isolation on health 
behaviors. A survey conducted during the H1N1 influenza pandemic indicated the im-
portance of precise information for reducing anxiety [9]. A rapid review on the impact of 
quarantine reported that when compared to mandated approaches, voluntary quarantine 
contributes to less distress and long-term complications [10]. 
It is well known that there are many shared determinants such as socioeconomic fac-
tors, health behaviors, psychological factors, and environmental factors that contribute to 
non-communicable and communicable diseases [1,11,12]. However, there are knowledge 
gaps about these relationships and how they differ across individuals with different 
health conditions. A better understanding of specific risk factors and mental health sup-
ports for individuals with different pre-existing medical conditions during the COVID-19 
pandemic will contribute to more effective program and policy interventions [13,14]. To 
address the needs of various knowledge users (e.g., policy-makers, program planners, 
health organizations and providers, end users), a scoping review was conducted, based 
on the following questions: 
i. What mental health conditions and substance use risk factors are related to the 
COVID-19 pandemic among populations with chronic physical health conditions 
who are at risk of contracting COVID-19 and having severe symptoms? 
ii. What are effective health promotion, primary prevention, screening, and treatment 
interventions to enhance mental health outcomes and to reduce risk of substance use 
for populations with chronic physical health conditions who are at risk of contracting 
COVID-19 and having severe symptoms?   
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2. Materials and Methods 
2.1. Search Strategy 
Our scoping review was guided by the Arksey and O’Malley methodology [15]. The 
literature search aimed to locate English and Chinese-language studies from December 
2019 to October 2020. December 2019 was when the Wuhan Municipal Health Commis-
sion in China reported the first cluster of cases with severe acute respiratory syndrome 
coronavirus 2 (SARS-CoV-2) in Wuhan, Hubei Province. The search strategy for English-
language literature included the following databases: MEDLINE (Ovid), Cumulative In-
dex to Nursing and Allied Health Literature (CINAHL), PsycInfo, Sociological Abstracts, 
and Embase. Other English-language search strategies included gray literature sources 
(e.g., COVID-related bulletins and correspondence) published between December 2019 
and October 2020, reference checking, and communications with knowledge users. The 
Chinese-language studies were searched using three bibliographic databases: two of the 
largest databases from Mainland China: (1) China National Knowledge Infrastructure 
(CNKI); (2) Wanfang Data; and one database from Taiwan: (3) Airiti Library. Search terms 
used were related to COVID-19, mental health, and physical health. Full details about the 
search strategy are outlined in Supplementary Table S1. 
2.2. Inclusion/Exclusion Criteria and Search Dates 
For both the English and Chinese-language literature searches, the following criteria 
were applied. Inclusion criteria: (i) English and Chinese-language articles from any coun-
try; (ii) full text available; (iii) adults age 18 years+; (iv) COVID-19 content. All study types 
or methodological approaches were included (i.e., qualitative, quantitative). At least one 
of the following physical health conditions needed to be included: obesity; diabetes; can-
cer or related terms (e.g., tumor, neoplasm, malignancy); cardiovascular disease; respira-
tory disease; autoimmune conditions; kidney disease; hepatitis; HIV or AIDS; frailty; neu-
rocognitive conditions, and/or functional limitations. Finally, eligible studies needed to 
include at least one of the following mental health conditions: depression; anxiety; bipolar 
disorder, mania; schizophrenia, schizoaffective; psychosis; obsessive disorders, neurosis; 
post-traumatic stress disorder (PTSD) or trauma; stress; substance use or related terms 
(e.g., addiction, compulsive drug abuse, drug dependence); behavioral addiction (e.g., 
gambling); impulsivity and/or disruptive, and impulse-control and conduct disorders. Ex-
clusion criteria: (i) studies that focused on health care workers; (ii) studies that focused on 
pregnancy, pediatrics, and populations less than 18 years old; (iii) studies that did not 
include COVID-19 or the health conditions outlined in the inclusion criteria. The English 
and Chinese-language literature searches were done at two time points: between 11 and 
13 June 2020 with updates between 11 and 17 October 2020. 
2.3. Screening, Data Extraction, and Quality Assessment 
The files from all database searches were imported to Covidence [16]. English litera-
ture abstracts and full texts were screened by two reviewers. For the Chinese-language 
literature, abstracts and full texts were screened by two reviewers who could read and 
speak Chinese fluently. When there was disagreement regarding the inclusion/exclusion 
between two reviewers, a senior researcher (K.D., S.L., or V.T.) made the final decision. 
Several recognized tools were used to assess the quality of evidence, sort the research 
studies, and extract the required data. For cohort studies, the Strengthening the Reporting 
of Observational Studies in Epidemiology (STROBE) checklist was used [17]. For RCTs, 
systematic reviews, and meta-analyses, the Meta-analyses Of Observational Studies in Ep-
idemiology (MOOSE) checklist was applied [18]. In addition, the Mixed Methods Ap-
praisal Tool (MMAT) was used [19]. After quality assessment, data extraction was con-
ducted where relevant information from each article was entered into a spreadsheet based 
on the PICOTS (Population, Intervention, Comparator, Outcome, Time, Setting) frame-
work [20] and quality assessment information. The data extraction was conducted by 
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trained research assistants with oversight from three senior research team members (K.D, 
S.L., V.T.). 
3. Results 
The results of the literature searches are outlined in Figures 1 (English) and 2 (Chi-
nese). Of the 4821 English-language references imported to Covidence for screening, 740 
duplicates were removed. After abstract and title screening, 178 studies were subse-
quently selected to undergo full-text screening. About one-third (n = 55) of the articles did 
not meet the inclusion criteria. The number of studies that underwent quality assessment 
was 123 and slightly more than 50% were excluded as they provided too limited infor-
mation pertaining to the research questions. A total of 60 English-language articles under-
went extraction. 
 
Figure 1. PRISMA diagram of English literature search results. 




Figure 2. PRISMA diagram of Chinese-language literature search results. 
For the Chinese-language literature search, a total of 822 titles and abstracts (Airiti 
Library n = 117; CNKI n = 240; Wanfang Data = 465) were located. Of these, 199 were 
duplicates. The 623 unique titles and abstracts were independently screened by two re-
viewers. When there was disagreement regarding inclusion/exclusion between two re-
viewers, a senior researcher (K.D., S.L.) reviewed the title and abstract and made the final 
decision. 140 full texts warranted full-text review, and 17 studies met the inclusion criteria 
and were included in the study. 
The studies originated from 17 countries. Most studies were from the United States 
(n = 18; 28%), followed by China (n = 8; 12%), Italy (n = 7; 11%), Spain (n = 5; 8%), Canada 
(n = 4, 6%), and India (n = 3, 5%). Other countries included Germany, Iran, Poland, Egypt, 
Ukraine, France, Australia, Brazil, Ireland, and Greece. The data extraction tables summa-
rizing the information derived from the 77 articles are located in Supplementary Tables 
S2 and S3. 
3.1. Results Relevant to Scoping Review Question 1 
Question: What mental health conditions and substance use risk factors are related 
to the COVID-19 pandemic among populations with chronic physical health conditions 
who are at risk of contracting COVID-19 and having severe symptoms? 
In the review literature, increased levels of substance use were associated with unex-
pected unemployment, social distancing, and quarantine during COVID-19 [21]. Anxiety 
and depression were the most commonly reported mental health conditions for individ-
uals with chronic health conditions during COVID-19 [22–27]. The following sections 
highlight literature findings of the most common mental health conditions (e.g., anxiety, 
depression) and substance use risk factors associated with specific physical comorbidities. 
As demonstrated in the following section, increased levels of adverse mental health con-
ditions were primarily associated with access to needed resources (e.g., health care team 
support); control or lack of control (e.g., ability to adhere to treatment regimen); or concern 
with contracting COVID-19.   
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3.1.1. Mental Health Conditions 
Individuals with Cancer 
In China, Zhao et al. [28] conducted a study centered on the psychological impact of 
the pandemic for individuals with a cancer diagnosis. The report indicated that 70% of the 
participants diagnosed with any type of cancer had some level of anxiety [28]. The key 
contributing factors to anxiety were female gender, being single, receiving in-hospital 
care, and lack of knowledge about infection prevention measures (p < 0.05) [28]. In another 
Chinese study by Chen et al. [29], researchers sampled individuals with cancerous tumors 
from five hospitals in Guangdong Province. Patients’ mental health was assessed using 
the Kessler Psychological Distress Scale (K-10). Of the 189 participants, 51% exhibited 
signs of psychological distress [29]. The researchers found a significant positive associa-
tion between COVID-19 disruption of patients’ surgery or treatment schedules and their 
distress scores. Almost one-quarter (23%) of participants reported that they could not see 
a doctor as frequently as usual [29]. 
Xu et al.’s [30] cross-sectional survey of 368 individuals with lung cancer from 25 
provinces in China found similar results. Between 40 and 75% of survey respondents re-
ported nervousness, anxiety, and/or quality of sleep disruption [30]. Interestingly, reports 
of anxiety among respondents were not related to fear of dying from COVID-19 [30]. The 
mental health measures that were used in this study were not clearly indicated. 
In an Italian retrospective cohort study that focused on anxiety among women ac-
cepting treatment for breast cancer in the context of the COVID-19 pandemic [31], there 
were significantly higher rates of refusal for procedures (p = 0.028) and surgeries (p = 
0.0065) in the COVID-19 period when compared to pre-COVID-19. The researchers hy-
pothesized that these refusals were due to women’s concerns of contracting COVID-19 
[31]. In this study, there was no specified measure used to assess anxiety. 
Individuals with Diabetes 
In India, Nachimuthu et al. [24] conducted an online pilot survey to study how peo-
ple with type 1 and type 2 diabetes were coping with their health conditions during the 
COVID-19 lockdown. Among 100 participants, 92% had type 2 diabetes, over 50% were 
males and over 65 years of age, and 8% had other physical complications, such as cardiac 
or kidney disease. Approximately two-thirds (65%) of the participants who were taking 
oral medications and insulin were not testing their blood glucose levels regularly. How-
ever, 80% of the sample reported that they were exercising regularly and following dietary 
recommendations. Almost half of the respondents (40%) were anxious about the COVID-
19 situation, and, at the time of this study, 73% believed their current situation would 
improve in the near future. Furthermore, about 8% of the study participants had cardiac 
and kidney complications; details about their mental health history were not reported. 
A study conducted in China [32] examined barriers during the pandemic for main-
taining a healthy mental state among 75 individuals with diabetes. The questionnaire the 
participants responded to included Zung’s Self-Rating Anxiety Scale and Self-Rating De-
pression Scale. Based on regression analysis, factors which contributed to anxiety and de-
pression included area of residence, presence of diagnosed cases of COVID-19 of people 
near the participant, whether there is sufficient mask supply, and availability of diabetes 
medication. An individuals’ ability to follow their medical doctor’s advice also impacted 
their mental state. When those who did not appear to follow their treatment plan were 
compared to those who did, depressive symptomatology was reported to be significantly 
higher (p < 0.05) [32]. 
Individuals with Epilepsy 
In a Chinese case-control study by Hao et al. [33], predictors of psychological distress, 
as measured by the 6-item Kessler Psychological Distress Scale, were compared for indi-
viduals with epilepsy (n = 252) and controls without epilepsy (n = 252). Individuals with 
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epilepsy had significantly higher distress scores than controls and spent significantly 
more time following the news about COVID-19 (p’s < 0.001). Results of multivariable lo-
gistic regression analysis identified two independent predictors of psychological distress: 
time spent paying attention to media reports related to COVID-19 (odds ratio (OR) = 1.17, 
95% CI 1.07–1.28) and diagnosis of drug-resistant epilepsy (OR = 0.28, 95% CI 0.13–0.62). 
Individuals with Obesity 
In Poland, an online survey was conducted with patients who were pre- (n = 258) and 
post-operative (n = 548) for bariatric surgery [34]. All respondents had physical health 
conditions, such as insulin resistance (n = 224), type 2 diabetes (n = 93), obstructive sleep 
apnea (n = 63), arterial hypertension (n = 265), dyslipidemia (n = 68), or arthritis/joint pain (n 
= 272). Almost three-quarters of respondents also reported high levels of anxiety (74.5%). 
The majority of respondents (72.3%) were aware that obesity was an important risk factor 
for heightened severity from COVID-19 infection. Despite this knowledge, about one-third 
(29.5%) of respondents had experienced weight gain with higher proportions among those 
who were pre-operative versus post-operative (43.8% vs. 22.7%; p < 0.001). Only 20.9% of all 
respondents had ongoing access to direct care from the bariatric team. Although remote 
access was reportedly available to 67% of the respondents, the researchers surmised that 
access challenges adversely influenced eating habits, levels of physical exercise, and psy-
chological distress, leading to deterioration of sustained weight loss for both populations 
[34]. Similarly, a review by Sockalingam et al. [35] reported that individuals undergoing 
bariatric surgery experienced increased levels of emotional distress. In this population, in-
creased stress can exacerbate eating psychopathology, adversely impact treatment adher-
ence, and contribute to poorer long-term health outcomes [35]. 
Individuals with Parkinson’s Disease 
A telephone survey conducted in Germany reported higher levels of anxiety (25.5%) 
in 99 individuals with Parkinson’s disease (PD) compared to 21 controls matched by age 
and gender (4.8%) [36]. The researchers found a significant positive correlation between 
severity of anxiety and fear of COVID-19 diagnosis among those with PD. Higher anxiety 
levels were also reported among individuals with PD who were concerned about drug 
availability during the lockdown as well as those with other chronic medical conditions. 
Among respondents with PD, stress-related psychiatric symptoms, including anxiety, 
were 30–40% more common than in the general population which was thought to be due 
to motor and cognitive inflexibility as well as reduced capacity to readily adapt to addi-
tional stressors from COVID-19 [36]. 
Individuals with Respiratory Conditions 
A small study conducted in China [37] studied a small number of individuals (n = 8) 
with a history of respiratory problems. The whole sample showed some evidence of post-
traumatic stress disorder (PTSD) related to fear of contracting COVID-19. The sleep qual-
ity of all these individuals was adversely affected, manifesting as night-time sleep diffi-
culties and early awakening. Disrupted sleep cycles are associated with symptoms of anx-
iety, PTSD, and depression, with severe cases leading to suicidal thoughts [37]. 
3.1.2. Substance Use 
Individuals with Risk Factors for Substance Use 
Only two studies were located that discussed substance use risk factors. A phone 
survey in Ukraine [38] examined the impact of social supports among older adults with 
HIV and substance use disorder (n = 123) during the COVID-19 lockdown. The 123 re-
spondents maintained their treatments throughout the COVID-19 lockdown; however, 
they still had anxiety about the availability of treatment services. Almost two-thirds (61%) 
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of respondents reported they had no one available as a treatment supporter. The authors 
noted that social support was critical for avoiding treatment interruptions [38]. 
In a cross-sectional study conducted in Poland [39], it was reported that individuals 
with substance use disorder and higher BMIs were adversely affected by quarantine dur-
ing COVID-19. Approximately 43% of individuals with higher BMIs increased their food 
intake; 51.8% did more snacking between meals; 14.6% consumed more alcohol; 45.2% 
reported increased smoking [39]. Among the 14.6% who reported increased alcohol use, 
the proportion was higher among those who reported they had an alcohol addiction. The 
authors noted that future research should try to determine whether the COVID-19-related 
lockdown has resulted in long-term reinforcement of adverse dietary habits and associ-
ated health issues, such as substance use [39]. 
3.2. Results Relevant to Scoping Review Question 2 
Question: What are effective health promotion, primary prevention, screening, and 
treatment interventions to enhance mental health outcomes and to reduce risk of sub-
stance use for populations with chronic physical health conditions who are at risk of con-
tracting COVID-19 and having severe symptoms? 
3.2.1. Individuals with Various Physical Health Conditions 
In a study that examined adults (n = 269) who had a disability or chronic condition 
[40], it was reported that perceived stress related to COVID-19 was positively correlated 
with self-distraction, denial, substance use, behavioral disengagement, venting, planning, 
religion, and self-blame. Results from the hierarchical regression analysis indicated that 
active coping, denial, use of emotional support, humor, religion, and self-blame were as-
sociated with well-being after controlling for demographic and psychological variables. 
Results of this study suggest that focusing efforts on positive coping may help mitigate 
stress associated with the COVID-19 pandemic among those with chronic conditions and 
disabilities [40]. 
In another study by Germani et al. [41], 1101 emerging adults (18–29 years old) were 
surveyed about their mental health responses to COVID-19. The survey included 
measures of the cultural dimensions on psychological maladjustment. Of the total sample, 
at least 31% had pre-existing physical or mental health conditions. The results indicated 
that perceptions of the self as part of a larger collective where all members of the collective 
are the same and equal [42] were associated with reduced emotional and behavioral dif-
ficulties, anxiety, and stress [41]. 
3.2.2. Health Promotion and Primary to Tertiary Prevention 
Within the extracted literature, many studies discussed the use of telehealth strate-
gies and online platforms to maintain access and communications with individuals. Men-
tal health promotion strategies focused on decreasing anxiety and depression by ensuring 
access to disease-specific care and to psychological supports. In some instances, the im-
portance of the family was highlighted. Some Chinese studies emphasized overarching 
prevention programs, facilitated by experts (e.g., psychologists, psychiatrists), that in-
clude content and resources on mental health, life guidance, and personality develop-
ment. Other Chinese papers and studies from other countries focused on specific inter-
ventions, such as cognitive behavioral therapy. Equity-seeking populations (e.g., racial-
ized communities) have inequitable access to the social determinants of health, predispos-
ing them to physical and mental health conditions—and to COVID-19. Community-based 
integrated physical and social care services are particularly important sources of health 
care support for vulnerable individuals. Examples follow of mental health promotion and 
prevention strategies for specific populations.   
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Individuals Living with Cancer 
An article by the International Geriatric Radiotherapy Group [43] discussed how to 
prevent depression and anxiety among older adults with cancer. Recommendations in-
cluded providing personalized care that is based on assessment of physical health and socio-
economic status, social services such as patient navigators, close monitoring via phone calls 
and telecommunications, and helping families provide psychological support [43]. 
A survey of people diagnosed with genitourinary cancers in Germany aimed to ex-
amine their perspectives on telehealth use during and after the pandemic [44]. Of the 101 
sampled, 92 responded to the questionnaire. Among the sample were individuals who 
also had underlying conditions such as cardiac disease, diabetes, renal disease, obesity, 
pulmonary disease, or a compromised immune system. For most participants, their anxi-
ety about cancer superseded that of contracting COVID-19 infection (p < 0.001). Most op-
posed interruptions to their treatment and highly rated the use of telehealth during the 
crisis, but they preferred it not continue after the pandemic. Most did not believe they 
were more susceptible to COVID-19 compared to the general population. This study sug-
gests that telehealth interventions are valuable in helping provide mental health services 
in a pandemic; however, there use otherwise needs to be further evaluated [44]. 
In a paper from China studying individuals with cancerous tumors, a 7-step preven-
tion strategy to protect people from psychological stress was used [45]. The strategy is 
based on three-over-arching components: mental health education, life guidance, and per-
sonality development. The steps are: [45]: 
i. accept that distress is a normal response to cancer and the COVID-19 epidemic; 
ii. trust the doctor and build a harmonious doctor-patient relationship; 
iii. maintain a stable life routine; be positive and optimistic; 
iv. communicate with relatives and friends; do not conceal your health status; 
v. arrange appropriate recreational activities every day and perform aerobic exercises 
when your physical condition allows. Recommended activities include yoga and tra-
ditional Chinese-based aerobic activities such as Tai Chi and Baduan Jin to balance 
qi (circulating life force); 
vi. establish a healthy sleep cycle and avoid using a mobile phone in bed; 
vii. when self-regulation cannot relieve anxiety, depression, and other emotions, seek 
professional help from a psychiatrist or psychologist. 
Those who proposed the 7-step strategy [45], were not optimistic about the preven-
tion and treatment of mental health symptoms in some types of cancers, such as hemato-
logical cancer. 
A Chinese paper [46] reported the use of an online hospital platform for providing 
mental health education led by psychology experts. Oncology and infection specialists 
were also available during online counseling sessions to answer questions about physical 
health and to provide the latest, accurate updates on COVID-19 [46]. No specific outcomes 
were reported about their interventions. 
Another Chinese study reviewed the merits of managing cancer patients’ psycholog-
ical distress during COVID-19 using the following interventions: cognitive behavioral 
therapy (CBT), mindfulness-based stress reduction (MBSR), and narrative therapy [47]. 
The authors reported that CBT intervention during the denial stage after cancer tumor 
diagnosis helped prevent maladaptive emotional, behavioral, and physical responses re-
lated to distorted beliefs [47]. Cognitive behavioral therapy, which challenges distorted 
beliefs, is associated with reductions in depression and stress responses and with in-
creased positive coping styles [47]. Mindfulness-based stress reduction directs the per-
son’s attention to the present situation and development of an accepting attitude. This 
approach decreases anxiety and depression symptomatology for patients with malignant 
tumors. Lastly, the authors described narrative therapy as a type of psychotherapy that 
helps foster a sense of security and inclusion. Overall, the authors supported the use of 
these therapies through hotline assistance and individual and group counseling [47]. 
Int. J. Environ. Res. Public Health 2021, 18, 7265 10 of 23 
 
 
In Italy, Vanni et al. [31] conducted a retrospective study to observe the refusal rate 
of breast cancer treatment in female breast cancer patients aged 45–80 before and after the 
COVID-19 pandemic. At the start of the pandemic, the refusal rate increased due to fear 
of COVID-19. The authors recommended psychological support to address COVID-19-
related anxiety and consultations with surgical oncologists to discuss the risks associated 
with refusing treatment (such as that for advanced breast cancer) [31]. 
Individuals Living with Other Chronic Health Conditions 
In order to effectively reduce psychological pressures in individuals with chronic 
kidney disease who need dialysis, a Wuhan hospital established a “five in one” mental 
health framework [48] that included the following components: 
i. strengthen health education related to COVID-19 through the WeChat online plat-
form; 
ii. increase information transparency to reduce anxiety, especially to correct misunder-
standings about the pandemic from unreliable sources; 
iii. strengthen the support offered by the doctor and family members. By receiving ex-
ternal support, patients may be better able to face the challenges of the pandemic; 
iv. provide nutrition guidance. Proteins are especially crucial, as the process of dialysis 
leads to a loss of proteins; 
v. guide individuals to use the professional mental health channel, as established by the 
hospital through the WeChat online platform. 
In a descriptive study by Zhang et al. [32], the mental health of people with diabetes 
in China focused on the importance of accurate, timely COVID-19 information tailored to 
those living at home. The researchers made reference to an online portal for mental health 
counseling. In addition to counseling, this online service provided timely, accurate infor-
mation about COVID-19, to alleviate distress for those with diabetes [32]. 
During the pandemic, older adults with chronic physical health conditions (e.g., dia-
betes mellitus, cardiovascular disease, immunocompromised, chronic lung conditions, re-
nal disease) had higher morbidity and mortality rates and significant adverse psychoso-
cial effects due to isolation and quarantine [49]. Common recommendations to address 
isolation for this population were telehealth technologies to conduct virtual clinician as-
sessment of physical and mental health risk factors and to provide prevention/promotion 
education (e.g., healthy dietary habits, stress reduction) and psychosocial supports [50]. 
In the US [51], social workers virtually collaborated with clients to address loneliness and 
chronic stress and to develop chronic disease self-management skills. In China, available 
family members were the primary care providers for older adults with physical health 
conditions at home [52]. Chinese nurses performed ongoing virtual/in-person assessments 
of older adults’ physical care needs and family members’ capacity to safely provide basic 
care, while both social workers [53] and nurses [52] conducted periodic virtual and/or in-
person mental health check-ins with at-home older adults, particularly solitary adults. 
During the pandemic, an overarching goal was to keep this population of seniors safe in 
their homes [52]. 
Individuals Living with Complications from COVID-19 
Complications due to COVID-19 are beginning to garner more attention. Ceravolo et 
al. [54] conducted a systematic rapid “living” review to determine the rehabilitation needs 
of individuals living with complications due to COVID-19 infection. Restricted mobility 
due to COVID-19 infection or lockdown warrant early rehabilitation (e.g., physiotherapy, 
exercise programs) and access to telehealth and telerehabilitation programs for individu-
als with complications. Of note, telehealth programs should address physical and “cogni-
tive” rehabilitation options based on needs assessments of individuals living with cardiac 
complications and disabilities resulting from COVID-19 [54]. 
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In a consensus statement on rehabilitation needs of long-COVID survivors, the most 
evidence-based recommendations (1a on the Oxford Levels of Evidence scale) included 
referrals to psychological services, trauma-focused cognitive behavioral therapy, and ac-
tive monitoring of those with subclinical psychological symptoms [55]. Lower quality rec-
ommendations (level 5 on the Oxford Levels of Evidence scale) included providing effective 
patient communication and remote social contact and reviewing mood and well-being of 
patients without psychological symptoms. A similar published clinical practice guideline 
[55] similarly recommended that primary care physicians should conduct social prescribing 
for individuals experiencing adverse psychological events during COVID-19. The evidence 
for social prescribing was not reported, but social prescribing enables physicians to connect 
individuals to community supports and activities geared towards social connectedness and 
mental well-being (e.g., yoga, art classes, virtual choir, online drawing classes). 
A randomized, controlled study that examined depression and anxiety in 26 Chinese 
individuals with COVID-19 (18–65 years old) was conducted [56]. The participants who 
were in an isolation ward were initially screened for psychological distress and followed 
for 2 weeks in an isolation ward. These patients all had pre-existing physical health con-
ditions (four had hypertension, two had liver disease, and one each had gastric ulcer, cor-
onary heart disease, or AIDS) [56]. The intervention group (n = 13) received a self-help 
internet-based intervention of breath relaxation training, mindfulness (body scan), “ref-
uge” skills, and the butterfly hug method. Intervention subjects listened to 50-min audio 
recordings via their mobile phones and followed intervention training instructions at a 
fixed time every day for two weeks. Those in the control received physical supportive care 
(n = 13). At baseline, there were no significant differences between the two groups for age, 
gender, severity of illness, and anxiety and depression scores. At the conclusion of the 
study, there were no main or interactive effects for age, gender, or severity of illness. At 
the end of the first week and the second week, the intervention group had significantly 
lower depression and anxiety scores compared to the control group [56]. 
Individuals Living with Dementia 
In China, practitioners were advised to create detailed contingency plans for virtual 
care and support of individuals with dementia and their families [57]. Virtual dementia 
care education for practitioners was also available through an online platform. 
For nursing home residents with Alzheimer’s, US researchers investigated the use of 
FaceTime interactions with family members to reduce behavioral problems [58]. Residents 
enjoyed FaceTime sessions, and they had improved appetites and decreased levels of anx-
iety and agitation. Families reported that FaceTime sessions created a sense of connected-
ness for them. Spanish researchers [59] trialed a television-based assistive integrated ser-
vice, TV-AssistDem, to support community-dwelling older adults living with mild de-
mentia, mild cognitive impairment, and/or anxiety. TV-AssistDem includes video inter-
actions with health care providers and can provide services such as reminders, cognitive 
stimulation, and health monitoring/data transmission. No evaluative data were available 
in this descriptive paper [59]. 
Brown et al. [60] recommended virtual care telehealth programs for older adults at 
home with Alzheimer’s disease and related dementias. They acknowledged, however, 
that virtual diagnosis and care via telephone or videoconferencing may not be sufficient 
to properly complete comprehensive physical and cognitive examinations for diagnostic 
purposes. 
Equity-Seeking Individuals with Pre-Existing Physical Health Conditions 
Systemic racial discrimination and stigma, particularly within communities of color 
(e.g., African American and Hispanic communities), increase vulnerability to the negative 
effects of COVID-19 [54,61]. Fortuna et al. [62] reported data from the Centers for Disease 
Control and Prevention demonstrating that Black Americans accounted for 34% of con-
firmed COVID-19 cases, despite only comprising 13% of the total US population. African 
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Americans were disproportionally at higher risk of COVID-19 infection due to pre-exist-
ing vascular and respiratory-related diseases and they encountered medical biases with 
respect to testing and treatment for COVID-19 [61]. For populations with physical and 
social care needs, integrated services in local communities are necessary to ensure equita-
ble access [62]. Features of effective integrated care include collaborative leadership and 
governance between services and community members—to effectively empower and en-
gage end users [62]. 
Access to HIV testing and treatment were adversely affected during the pandemic, 
particularly for equity-seeking populations [63–65]. Telemedicine initiatives for mental 
health assessments and HIV-related care were believed to be beneficial services for indi-
viduals with high-speed internet. Individuals with access issues to the social determinants 
of health, however, often had income barriers that challenged their capacity to engage in 
telehealth services—adversely affecting treatment adherence [63–65]. Rogers et al. [64] high-
lighted COVID-19 service adaptations for two US sexually transmitted infection (STI) clinics 
that provided evidence-based psychotherapy, HIV testing, substance use treatment, and 
other services geared towards sexual minority individuals. Virtual service transition failed 
for individuals who lacked stable housing and technology. To improve service access, the 
STI clinics eventually employed a more effective peer-based recovery model with peer 
coaches who provided flexible meeting times in convenient locations [64]. 
In a US survey study by Sanchez et al. [66], researchers assessed the COVID-19 im-
pacts on the sexual health of men who have sex with men (MSM) who were diagnosed 
with substance use disorder and HIV. Most survey respondents reported increased anxi-
ety (73.4%). Several participants identified problems with basic resource needs (e.g., diffi-
culty buying food, paying rent). These problems were more likely in younger participants 
(ages 15–24) who also reported increased recreational drug use and alcohol consumption 
compared to MSM respondents 25 years and older. Younger participants also reported 
more problems with access to testing and treatment related to HIV and sexually transmit-
ted infections. The authors’ primary recommendation was better telehealth services for 
physical and mental health needs [66]. 
Individuals Living with Substance Use 
Ahmed et al. [67] conducted a survey of individuals (14–68 years old) in Hubei, China 
with reported mental health concerns (depression, anxiety) and excess alcohol consump-
tion. In this cross-sectional study conducted during the pandemic, levels of anxiety and 
depression increased, mental well-being decreased, and alcohol consumption stayed rel-
atively the same. The authors provided several recommendations, such as restricted me-
dia exposure about COVID-19, access to online counseling for screening and treatment, 
proactive health care provider psychological training for vulnerable populations, and 
strategic planning for virtual rehabilitation services [67]. 
In the US, Da et al. [68] examined interventions during the COVID-19 pandemic for 
addressing the physical and mental health needs of individuals with alcohol use disorder 
(AUD) and alcohol-associated liver disease (ALD). Recommended interventions were use 
of telehealth and secure messaging services for 24/7 care related to alcohol counseling, 
screening, and surveillance for those at risk of relapse and addiction treatment. Mobile 
applications, such as EncephalApp, were instituted to assess cognitive function related to 
hepatic encephalopathy and to augment telehealth visits [69]. A notable recommendation 
was proactive planning for specialized, multidisciplinary integrated treatment centers to 
prepare for the expected increase in AUD, ALD, and the adverse physical and mental 
health effects associated with them [69]. 
4. Discussion 
The main objective of the scoping review was to capture evidence about what mental 
health promotion, prevention, and intervention strategies may reduce adverse mental 
health conditions and substance use risk factors related to the COVID-19 pandemic among 
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populations with chronic physical health conditions who are at risk of contracting 
COVID-19 and having severe symptoms. 
Much of the published literature highlighted mental health implications, including 
anxiety, depression, distress, disordered eating, and substance use, which occurred in in-
dividuals with chronic conditions such as cancer, cardiovascular disease, dementia, dia-
betes, HIV, and Parkinson’s disease. The fear of contracting COVID-19 among those who 
knew they were more susceptible to infection and the associated mental health impacts 
interfered with adherence to treatment plans. Several promising practices were described 
but not formally evaluated. The Chinese-language literature tended to discuss more self-
help and alternative measures, such as the butterfly hug technique, to manage mental 
health. The following accumulated evidence from the scoping review focuses on mental 
health promotion across the health care continuum, future research, and means to organ-
ize health and social services that are responsive to public health crises. 
4.1. Factors Contributing to Mental Health and Well-Being 
In the surveys about mental health responses to COVID-19 which compared those 
with and without chronic conditions, higher levels of distress tended to be reported 
among those with a chronic physical health condition [56,70]. There are multiple intersect-
ing individual, community, and societal level factors that may contribute to mental health 
and well-being among those who have a chronic physical health condition that places 
them at risk of severe COVID-19 infection (Figure 3). First, as shown in Figure 3, there are 
structural level drivers that include ecological (e.g., food supply and availability), eco-
nomic (e.g., income supports), and social factors (e.g., mental health stigma) that affect 
community and individual level health. At the community level, the pandemic’s effects 
include outcomes such as increasing economic instability and social isolation as well as 
decreasing access to health and social care services. It is well established that chronic phys-
ical health conditions such as obesity, diabetes, cancer, cardiovascular disease, chronic 
respiratory diseases, chronic kidney and liver diseases, autoimmune conditions, HIV, 
hepatitis, and frailty present risk for severe COVID-19 infection [4]. Furthermore, mental 
health problems and conditions such as major depression, schizophrenia spectrum condi-
tions, psychosis, anxiety disorders, and bipolar affective disorders are commonly comor-
bid among various chronic physical health conditions, including diabetes, cancer, cardio-
vascular disease, chronic respiratory diseases, arthritis, and inflammatory bowel disor-
ders [71–77]. The co-occurrence of physical and mental health issues results from an in-
terplay of biological factors (e.g., increased inflammatory response), genetic predisposi-
tion, behavioral factors such as poor diet, physical inactivity, or substance use, and psy-
chosocial factors such as illness experience [78]. These factors impact an individual’s cop-
ing and resilience [79] and increase the likelihood that the person living with a physical 
health condition will have mental health responses such as anxiety, depression, or sub-
stance use. Alternatively, if they have a co-existing mental health condition, their symp-
toms may worsen [5,6]. 




Figure 3. Factors impacting mental health for those with physical health conditions that present risk 
of severe COVID-19 infection. 
4.2. Mental Health Promotion and Policy 
Of the extracted studies, there did not appear to be explicit discussion about health 
and social policies aimed at modifiable targets, such as income, to help prevent or manage 
mental health concerns during the pandemic. As Horton suggests [80], SARS-CoV-2 in-
teracts with an array of non-communicable diseases and these conditions cluster within 
subpopulations according to patterns of deeply embedded inequality. Furthermore, the 
nature of the COVID-19 threat, which includes interactions of biological, psychological, 
and social factors that impact health, points to the need for proactive and nuanced ap-
proaches to protect the health of communities. Certain health and social policies may help 
to create supportive environments for mental health promotion across different popula-
tions. Some examples of policy areas that elevate population mental health include 
healthy child development, mental health screening, the social determinants of health 
(e.g., income, education, literacy) and socio-economic inequities [81–83]. In addition, di-
rectives towards ensuring consistent and appropriate access to mental health services, in-
cluding specialist services, can help maintain mental health and well-being, especially 
during public health crises. 
Some literature has highlighted policies aimed at substance use during the pandemic 
[84]. For example, psychosocial crises may trigger alcohol abuse that in turn may contrib-
ute to impulsivity, aggressiveness, loneliness, and hopelessness [85]. Strategies to monitor 
alcohol consumption during pandemics are recommended with restriction of access as 
needed to reduce risk of abuse. Furthermore, policy targets aimed at reducing risk factors 
for substance use, such as unemployment [86,87], may help to prevent substance abuse 
during public health crises.   
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4.3. Health Education and Literacy 
One of the main consequences of the COVID-19 pandemic has been the dissemina-
tion of rumors and health misinformation through media and social networks [88] which 
has the potential to lead to reactions that can worsen mental health [89,90]. As identified 
by researchers and decision makers, parallel to the current pandemic has been a massive 
“infodemic” of rapidly spreading misinformation through social media platforms and 
other outlets [89]; this needs to be addressed by the public health community who can 
educate and support social and conventional media to positively deliver information from 
health, medical, and scientific communities [90]. 
Individual health literacy is defined as the extent to which people have the capacity 
to obtain, process, and understand basic health information and services needed to make 
appropriate health decisions [91]. As suggested by different investigators [36,39], low 
health literacy may have contributed to adverse mental health responses during the 
COVID-19 pandemic. Lower levels of health literacy are associated with both poorer phys-
ical and mental health [91,92]. Health literacy policies and programs, such as aids to im-
prove self-management of chronic diseases, should target vulnerable groups, such as 
those with lower levels of education, lower incomes, and low language proficiency to en-
sure equitable access to vital information [92]. 
A barrier to mental health that was not identified in the studies, but which has been 
reported elsewhere [93], are the stigmas that can occur with both physical and mental 
health conditions. Physical health conditions such as obesity, lung cancer, and arthritis 
may be prone to associated stigmas [94], with reported negative effects including anxiety 
[95], stress [96], depression [97], and reduced self-esteem/self-efficacy [98]. Studies also 
suggest that, as physical health worsens, the risk of experiencing discrimination increases 
[99]. Some investigators have also pointed to the ageist rhetoric which has been a domi-
nant theme during the COVID-19 pandemic [99]. Public health education campaigns 
aimed at reducing stigmas can help shape more positive attitudes about illness and aging 
and increase the quality of life of those targeted by stigma [99,100]. 
4.4. Health and Social Care Delivery 
Prior to the pandemic, it was identified that there was a need for more integrated 
physical, mental, and social health care services. Integrated services are associated with 
reduced morbidity, premature death prevention, improved service access and service 
transitions across health care, enhanced service sustainability and stability, and improved 
community health [101]. In many countries, the collaborative care model is considered 
best practice for optimal physical and mental health integration. Collaborative care mod-
els have supported important innovations associated with mental health promotion such 
as crisis helplines to help identify and intervene in emerging psychosocial crises [102], 
expanded social worker roles and the inclusion of case managers to help monitor individ-
uals at risk for poor mental health [102], and social prescribing practices that connect in-
dividuals to community-based services and activities, including meditation and yoga clas-
ses [103]. 
Collaborative practice is broadly defined as a multi-professional approach of shared 
communications and decision-making with patients at the center of care. Collaborative 
models of care are typically community-based primary points of service contact for end 
users [104,105]. This evidence-based model of care has faced implementation and sustain-
ability challenges due to lack of adequate resources. Lack of resources to support collabo-
rative care became apparent during the pandemic, when many community-based services 
closed down due to fear of COVID-19 outbreaks [106]. Achieving capacity for more resil-
ient and flexible collaborative care will require increases in human resources and enhance-
ments in technology that facilitate sharing of information [102]. 
Strategies that facilitate collaborative care and integrated health and social care in-
clude [107–109]: 
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 registries of people with complex needs to track preventative care, disease/illness 
management, and referrals to secondary and tertiary care services; 
 health care system navigation supports and shared decision-making approaches; 
 competencies among practitioners to deliver high-quality health care to people with 
mental health problems; 
 training practitioners in the recovery model, including stigma, discrimination, and 
trauma-informed care; 
 evidence-based mental health screening guidelines with accompanying management 
pathways. 
Another alternative model of care is group medical visits for individuals who share 
the same chronic condition. Usually after an initial screening visit with a practitioner, in-
dividuals are invited to attend group sessions to receive care, education, and advice 
within a supportive group environment [110]. These visits may also include other practi-
tioners such as nurses, dieticians, and social workers. Group medical visits are cost-effec-
tive alternatives to individual psychiatric outpatient care or mental health care for indi-
viduals with moderate or severe mental illness [111]. This model of care has been deliv-
ered through secured videoconferencing, however, to the best of our knowledge, the ef-
fectiveness of a virtual approach to group medical visits has not been evaluated. 
Patient navigator systems that guide individuals through the health system, accord-
ing to their treatment needs [112], may be effective mechanisms to support mental health. 
Patient navigators may be nurses, social workers, lay health workers, or peers. Specific 
tasks of the navigators may include providing disease and health system education, ad-
dressing financial barriers, conducting care coordination, and providing emotional sup-
port [113]. These programs have been used for people with HIV/AIDS, cardiovascular 
disease, chronic kidney disease, dementia, and individuals with comorbidities [113]. One 
9-month RCT of 432 women with a chronic health condition assigned participants to either 
a public health nurse case manager or a wait-list control group. From study onset to com-
pletion, the intervention group reported significant decreases in depression scores and 
improvements in functional status compared to the control group (p = 0.016) [113]. This 
service delivery model may prove useful during times of disease outbreaks where navi-
gators can assist people through the health system, potentially through the use of digital 
applications. 
The use of different wireless technologies to support the achievement of health ob-
jectives [114], known as m-health, has been discussed in some of the papers of this scoping 
review [44,58,62,67]. Most discussions focused on resources and services provided via the 
internet, videoconferencing, or mobile apps that monitor both physical and mental health 
symptoms. Enhancing delivery of mental health care using m-health applications can also 
increase the effectiveness of paraprofessionals, peer helpers, and mutual aid organizations 
[115] and augment telehealth visits [116]. 
One of the most widely investigated m-health applications used in the context of cri-
ses such as wars and natural disasters has been PTSD Coach, which may have applications 
in infectious disease pandemics [116–121]. An RCT of PTSD Coach was conducted prior 
to the COVID-19 pandemic with 120 community trauma survivors [121] who reported 
significant reductions in PTSD and depression severity and improved psychosocial func-
tioning relative to wait-list controls. These study results occurred after three months of 
PTSD Coach app use by the intervention group [121]. A variety of web-based interven-
tions for combat veterans experiencing post-traumatic stress difficulties have successfully 
reduced PTSD symptoms, depression, and/or alcohol use [119–121]. Ideally, such m-ap-
plications should include features such as monitoring of wellness, cognitions, and emo-
tions [121]. Digital reality applications, such as virtual reality (VR), are being explored to 
help improve mental health. For example, at Cedars-Sinai Medical Center in Los Angeles, 
VR is being applied during the COVID-19 pandemic to deliver mind-body treatments in 
three-dimensional worlds for people in their homes [122]. 
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Although m-health applications are recognized as viable alternatives to health care de-
livery, particularly during the pandemic, equitable access remains an ongoing concern. Cer-
tain populations, such as those from racial and ethnic minority groups, have been dispro-
portionately burdened by disparities in digital access during the pandemic, and these may 
intersect with other forms of structural disadvantage and exacerbate the consequences of 
COVID-19 [123]. Future policy considerations must aim to eliminate digital health inequities 
by increasing access to broadband internet and improving digital literacy [123]. 
4.5. Mental Health Screening and Assessment 
Mental health screening among those with physical health conditions is a recom-
mended standard of practice [124], particularly in the context of the COVID-19 pandemic. 
There is considerable heterogeneity among the measures being employed, some of which 
have also not been validated for use in people with different health conditions. Tools to 
assess mental health for those with chronic physical health conditions and who are at risk 
of communicable disease should account for symptoms (e.g., fatigue), stress, quality of 
life, risk factors, and protective factors. Brief screening tools, such as the two-item Patient 
Health Questionnaire (PHQ-2), may be feasible for use during virtual visits or as part of 
testing for COVID-19. If more comprehensive assessment is needed, people can be sched-
uled for an assessment with standardized instruments validated for their particular cir-
cumstances (e.g., health condition) [124]. 
Gatekeeper training involves training key people, such as first responders, to identify 
individuals experiencing mental health issues [125]. In the context of the pandemic, it may 
be helpful to train gatekeepers in the general population (e.g., teachers). Programs such 
as Mental Health First Aid—Australia incorporate gatekeeper training that has been ef-
fective for improving knowledge and attitudes and promoting helping behaviors towards 
adults with mental health problems [125]. 
4.6. Psychological, Lifestyle, and Peer Approaches 
Scoping review recommendations to promote mental health during the pandemic 
included self-care and some standard mental health interventions, such as cognitive be-
havioral therapy (CBT). Brief CBT interventions focused on the identification of warning 
signs, coping skills, social support, professional help, and crisis planning have been effec-
tive in preventing suicidal thoughts and behavior [126]. While CBT is considered a cor-
nerstone of mental health care, the literature does not demonstrate its efficacy for individ-
uals with different chronic physical health conditions. 
Similar to the psychosocial intervention literature, there was limited discussion in 
review papers about lifestyle and peer-based interventions to improve mental health out-
comes. Lifestyle interventions such as physical activity, diet, and mindfulness-based med-
itation techniques may promote mental health when used as adjuncts to evidence-based 
physical care regimens for individuals with chronic physical health conditions [127]. Peer 
support approaches is another recommended model for mental health care. Evidence has 
shown it promotes early help-seeking, prevents mental health-related hospitalizations, re-
duces extended hospital stays, and eases demands for more specialized mental health 
professionals [128]. 
4.7. Strengths and Limitations of the Scoping Review 
This review contributes to an understanding of mental health responses among peo-
ple with physical health conditions that present risk of having severe infection from 
COVID-19. It also highlighted interventions that may help prevent and manage mental 
health responses in these populations. The use of a scoping review provided broad cov-
erage of the literature highlighting the main issues that can help provide the information 
needed for health policy, clinical practice, and future research. Although many literature 
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sources were searched, due to the rapid timeline for the review, we were unable to con-
tinuously search for and integrate new peer-reviewed and gray literature sources in Eng-
lish or Chinese. 
5. Conclusions 
There are various interventions that may foster mental health for those with chronic 
physical health conditions in the context of a pandemic; however, an evidence base out-
lining their effectiveness is lacking. A better understanding of the shared etiology of men-
tal and physical health will lead to more targeted and personalized approaches to care. In 
addition, more knowledge about integrated health and social care implementation and 
outcomes are needed. Many health-related innovations, such as telehealth technologies, 
were trialed during the pandemic. Further evaluation is required to determine the efficacy 
of these innovations, including ways to adapt and adopt them for different populations 
and settings, such as equity-seeking populations with barriers to the social determinants 
of health. This knowledge synthesis proposed many directions to take in our exploration 
of mental health promotion, prevention, and intervention for individuals living with 
chronic physical health conditions during the COVID-19 pandemic. Hopefully, this re-
view will serve as a stepping stone for future researchers, policy-makers, practitioners, 
educators, and end users. 
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